NPI registry status
Active
2026 NPPES data Hematology & Oncology Physician NPI 1467724286 MD
Verify on CMS → Ivette Vigoda, MD
Hematology & Oncology Physician in Bronx, New York.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 11,232 in Hematology & Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
779
Medicare Part D claims · 103 beneficiaries · Hematology & Oncology Physician avg: 847
Generic prescribing
0%
generic claims · 51% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$2.8K
106 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Ivette Vigoda, MD filed 779 Medicare Part D claims in 2023 as a Hematology & Oncology Physician in Bronx, New York, prescribing 0% generic.
- 779
- Part D claims, 2023
- 0%
- generic prescribing
- Likely
- board-certified (heuristic)
- ≥71st
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
CMS NPPES provider registry desk
NPI 1467724286 · Hematology & Oncology Physician
NPI-10 · ENUM-MID · TAX-MID · RX-LIGHT · BOOK-LIGHT · PHOTO-ENUM
- NPI-10 1467724286
- ENUM-MID 2012
- TAX-MID 11K Hematology &
- RX-LIGHT 779
- BOOK-LIGHT 967 in New York
- PHOTO-ENUM Vinh Trang · 2012
Ivette Vigoda, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
779 ≥ 71st percentile 71% of 1,370,886 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2023
✓
Board certification likely (heuristic, not verified)
Ivette Vigoda, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Ivette Vigoda, MD?
Quality data not reportedPrimary specialty
Hematology & Oncology Physician
Medicare Part D claims
779 8% vs specialty avg
Specialty distribution in New York
How Hematology & Oncology Physician compares to other specialties among New York providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Hematology & Oncology Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1467724286 |
|---|---|
| Specialty | Hematology & Oncology Physician |
| Credentials | MD |
| Gender | Female |
| NPI Issued | 02/09/2012 |
Hospital and facility affiliations
Facilities where Ivette Vigoda, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Sbh Physicians PC
Bronx, NY
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Ivette Vigoda, MD. Source: openpaymentsdata.cms.gov.
Total received
$2.8K
Largest payer
Novartis Pharmaceuticals Corporation
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - New York NYSBPMC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 - they are NOT specific to Ivette Vigoda, MD. To verify Ivette Vigoda, MD's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases
NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Brand-heavy
Ivette Vigoda, MD - brand share 51.0%
Hematology & Oncology Physician average
51% brand-name claims vs 0% generic, on 779 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
779
Total Claims
$3.8M
Total Drug Cost
103
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 1,025
- Total Day Supply
- 27,964
- Brand vs Generic
- 51% brand / 0% generic
- Brand Drug Cost
- $3.5M
- Opioid Claims
- 33 (4.2% rate)
Patient Demographics
- Average Patient Age
- 72.1 years
- Avg HCC Risk Score
- 2.04
- Gender Split
- 68% female / 32% male
- Age Distribution
- <65: 17, 65-74: 41, 75-84: 34, 85+: 11
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Ivette Vigoda, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Xgeva
Xgeva
57 claims
- Darzalex Faspro
Darzalex Faspro
49 claims
- Letrozole
Letrozole
49 claims
- Anastrozole
Anastrozole
42 claims
- Warfarin Sodium
Warfarin Sodium
31 claims
- Ondansetron Hcl
Ondansetron Hcl
30 claims
- Valacyclovir
Valacyclovir
29 claims
- Prolia
Prolia
25 claims
| Drug | Claims |
|---|---|
| Xgeva Denosumab | 57 |
| Darzalex Faspro Daratumumab-Hyaluronidase-Fihj | 49 |
| Letrozole | 49 |
| Anastrozole | 42 |
| Warfarin Sodium | 31 |
| Ondansetron Hcl | 30 |
| Valacyclovir Valacyclovir Hcl | 29 |
| Prolia Denosumab | 25 |
| Xarelto Rivaroxaban | 25 |
| Revlimid Lenalidomide | 24 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Hematology & Oncology Physician Overview
How Ivette Vigoda, MD fits within the Hematology & Oncology Physician landscape nationally.
11,232
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider
Ivette Vigoda, MD's 779 claims are below the specialty average of 847.
Nationwide Hematology & Oncology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Vigoda, both outside New York so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2012)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Hematology & Oncology Physician Providers in New York
Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as Vigoda.
One of 967 Hematology & Oncology Physician providers enrolled in New York, 5 are shown here.
Dr. Anum Aamir
M.D
Astoria, NY
Dr. Robert Abderhalden
MD
Painted Post, NY
Dr. Mohammad Maher Abdul Hay
MD
New York, NY
Dr. George Abraham
MD
Rochester, NY
Dr. Avram Abramowitz
M.D.
Fresh Meadows, NY
Compare Hematology & Oncology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Ivette Vigoda, MD's specialty? ▼
Ivette Vigoda, MD specializes in Hematology & Oncology Physician and practices in Bronx, New York. Credentials: MD.
How much does Ivette Vigoda, MD prescribe under Medicare Part D? ▼
In 2023, Ivette Vigoda, MD wrote 779 Medicare Part D claims totaling $3.8M in drug costs for 103 beneficiaries.
Where is Ivette Vigoda, MD located? ▼
Ivette Vigoda, MD is located at 4422 3RD AVE, Bronx, NY, 10457. Phone: (718) 960-6205.
What is Ivette Vigoda, MD's NPI number? ▼
Ivette Vigoda, MD's National Provider Identifier (NPI) is 1467724286, issued on 02/09/2012.
Does Ivette Vigoda, MD prescribe more brand-name or generic drugs? ▼
Ivette Vigoda, MD's prescribing is 51% brand-name and 0% generic drugs by claim count, with $3.5M in brand drug costs.
Does Ivette Vigoda, MD prescribe opioids? ▼
Yes, Ivette Vigoda, MD had 33 opioid claims in 2023 with an opioid prescribing rate of 4.2%.
How many Hematology & Oncology Physician providers are there in the US? ▼
There are 11,232 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does Ivette Vigoda, MD prescribe most often? ▼
Based on 2023 Medicare Part D data, Ivette Vigoda, MD's most frequently prescribed drugs include Xgeva, Darzalex Faspro, Letrozole. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Ivette Vigoda, MD accept Medicare? ▼
Ivette Vigoda, MD appears in CMS Medicare data with 779 Part D claims and 103 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Ivette Vigoda, MD's credentials? ▼
Ivette Vigoda, MD's NPI is 1467724286 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.